Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer

Clinical trial NCT00383331 · TERMINATED

Trial details

NCT number: NCT00383331
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small-Cell Lung Cancer

Start date: 2007-02-01
Primary completion: 2008-01-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.